Clinical trials
Terminated Central Nervous System Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
67 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 5 |
| 2002 | 3 |
| 2003 | 4 |
| 2004 | 6 |
| 2005 | 5 |
| 2006 | 4 |
| 2007 | 3 |
| 2008 | 6 |
| 2009 | 3 |
| 2010 | 3 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 67 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pediatric Brain Tumor Consortium | 7 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 7 |
| M.D. Anderson Cancer Center | 5 |
| National Cancer Institute (NCI) | 4 |
| OHSU Knight Cancer Institute | 3 |
| Children's Hospital of Philadelphia | 2 |
| City of Hope Medical Center | 2 |
| Masonic Cancer Center, University of Minnesota | 2 |
| UNC Lineberger Comprehensive Cancer Center | 2 |
| Vanderbilt-Ingram Cancer Center | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Central Nervous System Neoplasms | 67 |
| Astrocytoma | 21 |
| Brain Neoplasms | 21 |
| Glioblastoma | 19 |
| Gliosarcoma | 17 |
| Oligodendroglioma | 17 |
| Medulloblastoma | 12 |
| Glioma | 11 |
| Lymphoma | 9 |
| Rhabdoid Tumor | 8 |
Trials
Showing 1 to 25 of 67. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.